Excise duty exemption for rifampicin formulations: specified single ingredient and combination antitubercular medicines relieved from central excise obligation. Exemption from whole central excise duty is provided for single ingredient Rifampicin formulations and formulations combining Rifampicin with Isoniazid, and Rifampicin with Isoniazid and Pyrazinamide, falling under the medicaments tariff heading. Covered products are defined as medicaments processed from the named bulk drugs, with or without inert pharmaceutical aids that do not interfere with therapeutic activity, intended for diagnosis, treatment, mitigation or prevention of disease in humans or animals; substances outside drug control provisions are excluded.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Excise duty exemption for rifampicin formulations: specified single ingredient and combination antitubercular medicines relieved from central excise obligation.
Exemption from whole central excise duty is provided for single ingredient Rifampicin formulations and formulations combining Rifampicin with Isoniazid, and Rifampicin with Isoniazid and Pyrazinamide, falling under the medicaments tariff heading. Covered products are defined as medicaments processed from the named bulk drugs, with or without inert pharmaceutical aids that do not interfere with therapeutic activity, intended for diagnosis, treatment, mitigation or prevention of disease in humans or animals; substances outside drug control provisions are excluded.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.